DIA 2021 Biosimilars USA

Home/Conferences | Posted 27/08/2021

Biosimilars Conference
5-6 October 2021
Virtual Event

Joint 26th Medicines for Europe and 23rd IGBA Annual Conference 2021

Home/Conferences | Posted 15/11/2019

Joint 26th Medicines for Europe and 23rd IGBA Annual Conference 2021
6-8 October 2021
Divani Apollon Hotel, Athens

AAM GRx+Biosims 2021

Home/Conferences | Posted 23/07/2021

GRx+Biosims 2021
8−10 November 2021
Virtual Conference

Medicines for Europe 16th Legal Affairs Conference 2021

Home/Conferences | Posted 21/02/2020

16th Legal Affairs Conference 2021
September 2021
The Tower Hotel, London

Terrapinn Festival of Biologics 2022

Home/Conferences | Posted 10/09/2021

Terrapinn Festival of Biologics San Diego
9–11 March 2022
San Diego, USA

Microbiological control symposium: consensus on readiness of new methods emerges

Home/Conferences | Posted 27/10/2017

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

European Pharmacopoeia prepares for the future through exchange with stakeholders

Home/Conferences | Posted 14/10/2016

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

French generics association promotes biosimilars

Home/Conferences | Posted 17/10/2014

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Home/Conferences | Posted 17/01/2014

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

Home/Conferences | Posted 21/06/2013

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.